Oh SC - Search Results

1

NgR1 is an NK cell inhibitory receptor that destabilizes the immunological synapse.

Oh SC, Kim SE, Jang IH, Kim SM, Lee SY, Lee S, Chu IS, Yoon SR, Jung H, Choi I, Doh J, Kim TD. Oh SC, et al. Nat Immunol. 2023 Mar;24(3):463-473. doi: 10.1038/s41590-022-01394-w. Epub 2023 Jan 9. Nat Immunol. 2023. PMID: 36624164

2

MicroRNA-150 modulates intracellular Ca ²⁺ levels in naïve CD8⁺ T cells by targeting TMEM20.

Kim TD, Jung HR, Seo SH, Oh SC, Ban Y, Tan X, Min Kim J, Hyun Lee S, Koh DS, Jung H, Park YJ, Ran Yoon S, Doh J, Ha SJ, Choi I, Greenberg PD. Kim TD, et al. Among authors: oh sc. Sci Rep. 2017 Jun 1;7(1):2623. doi: 10.1038/s41598-017-02697-x. Sci Rep. 2017. PMID: 28572627 Free PMC article.

3

MicroRNA-150 controls differentiation of intraepithelial lymphocytes through TGF-β receptor II regulation.

Seo SH, Jang MS, Kim DJ, Kim SM, Oh SC, Jung CR, Park Y, Ha SJ, Jung H, Park YJ, Yoon SR, Choi I, Kim TD. Seo SH, et al. Among authors: oh sc. J Allergy Clin Immunol. 2018 Apr;141(4):1382-1394.e14. doi: 10.1016/j.jaci.2017.07.019. Epub 2017 Aug 7. J Allergy Clin Immunol. 2018. PMID: 28797734

4

miR-150-Mediated Foxo1 Regulation Programs CD8⁺ T Cell Differentiation.

Ban YH, Oh SC, Seo SH, Kim SM, Choi IP, Greenberg PD, Chang J, Kim TD, Ha SJ. Ban YH, et al. Among authors: oh sc. Cell Rep. 2017 Sep 12;20(11):2598-2611. doi: 10.1016/j.celrep.2017.08.065. Cell Rep. 2017. PMID: 28903041 Free article.

5

Tryptophanyl-tRNA Synthetase as a Potential Therapeutic Target.

Ahn YH, Oh SC, Zhou S, Kim TD. Ahn YH, et al. Among authors: oh sc. Int J Mol Sci. 2021 Apr 26;22(9):4523. doi: 10.3390/ijms22094523. Int J Mol Sci. 2021. PMID: 33926067 Free PMC article. Review.

6

The Role of IL-7 and IL-7R in Cancer Pathophysiology and Immunotherapy.

Wang C, Kong L, Kim S, Lee S, Oh S, Jo S, Jang I, Kim TD. Wang C, et al. Int J Mol Sci. 2022 Sep 8;23(18):10412. doi: 10.3390/ijms231810412. Int J Mol Sci. 2022. PMID: 36142322 Free PMC article. Review.

7

A modifiable universal cotinine-chimeric antigen system of NK cells with multiple targets.

Kang HY, Lee SY, Kim HM, Lee SU, Lee H, Cho MY, Oh SC, Kim SM, Park HS, Han EH, Kim SE, Kim H, Yoon SR, Doh J, Chung J, Hong KS, Choi I, Kim TD. Kang HY, et al. Among authors: oh sc. Front Immunol. 2023 Jan 13;13:1089369. doi: 10.3389/fimmu.2022.1089369. eCollection 2022. Front Immunol. 2023. PMID: 36713381 Free PMC article.

8

FTO negatively regulates the cytotoxic activity of natural killer cells.

Kim SM, Oh SC, Lee SY, Kong LZ, Lee JH, Kim TD. Kim SM, et al. Among authors: oh sc. EMBO Rep. 2023 Apr 5;24(4):e55681. doi: 10.15252/embr.202255681. Epub 2023 Feb 6. EMBO Rep. 2023. PMID: 36744362 Free PMC article.

9

Understanding nucleic acid sensing and its therapeutic applications.

Kong LZ, Kim SM, Wang C, Lee SY, Oh SC, Lee S, Jo S, Kim TD. Kong LZ, et al. Among authors: oh sc. Exp Mol Med. 2023 Nov;55(11):2320-2331. doi: 10.1038/s12276-023-01118-6. Epub 2023 Nov 9. Exp Mol Med. 2023. PMID: 37945923 Free PMC article. Review.

10

Bemarituzumab as first-line treatment for locally advanced or metastatic gastric/gastroesophageal junction adenocarcinoma: final analysis of the randomized phase 2 FIGHT trial.

Wainberg ZA, Kang YK, Lee KW, Qin S, Yamaguchi K, Kim IH, Saeed A, Oh SC, Li J, Turk HM, Teixeira A, Hitre E, Udrea AA, Cardellino GG, Sanchez RG, Zahlten-Kümeli A, Taylor K, Enzinger PC. Wainberg ZA, et al. Among authors: oh sc. Gastric Cancer. 2024 May;27(3):558-570. doi: 10.1007/s10120-024-01466-w. Epub 2024 Feb 3. Gastric Cancer. 2024. PMID: 38308771 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

252 results

Search Page